Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2c receptor (Q28293888)

2

0 references

H Majasuo

3

0 references

A Laakso

4

0 references

M Kuoppamäki

5

0 references

E Syvälahti

6

0 references

J Hietala

Human brain fluoxetine concentrations.

7

0 references

language of work or name

English

0 references

publication date

August 1996

0 references

published in

Psychopharmacology

0 references

volume

126

0 references

issue

3

0 references

page(s)

234-40

0 references

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02246453

Protein kinase C in rat brain cortex and hippocampus: effect of repeated administration of fluoxetine and desipramine

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02246453

Fluoxetine: a serotonin-specific, second-generation antidepressant

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02246453

Interaction of subtype-selective antagonists with alpha 1-adrenergic receptor binding sites in rat tissues

21 January 2018

1 reference

12 December 2020

Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands

1 reference

12 December 2020

Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists

1 reference

12 December 2020

Agonist-induced phosphoinositide hydrolysis in choroid plexus.

1 reference

12 December 2020

Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors

1 reference

12 December 2020

Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors

1 reference

12 December 2020

Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs

1 reference

12 December 2020

Distribution of serotonin 5-HT1C receptor mRNA in adult rat brain

1 reference

12 December 2020

5-HT1c receptor is a prominent serotonin receptor subtype in the central nervous system

1 reference

12 December 2020

Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists.

1 reference

12 December 2020

Importance of duration of drug action in the antagonism of p-chloroamphetamine depletion of brain serotonin—comparison of fluoxetine and chlorimipramine

1 reference

12 December 2020

Fluoxetine: a review of receptor and functional effects and their clinical implications.

1 reference

12 December 2020

The mammalian beta 2-adrenergic receptor: reconstitution of functional interactions between pure receptor and pure stimulatory nucleotide binding protein of the adenylate cyclase system

1 reference

12 December 2020

Effects of short- and long-term administration of fluoxetine on the monoamine content of rat brain

1 reference

12 December 2020

Identification of the 5-hydroxytryptamine2C receptor as a 60-kDa N-glycosylated protein in choroid plexus and hippocampus.

1 reference

12 December 2020

Chronic clozapine treatment down-regulates serotonin 5-HT-1c receptors in rat brain

1 reference

12 December 2020

Inverse agonism: pharmacological curiosity or potential therapeutic strategy?

1 reference

12 December 2020

[3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role.

1 reference

12 December 2020

Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors.

1 reference

12 December 2020

Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.

1 reference

12 December 2020

5-HT1C receptor-mediated phosphoinositide hydrolysis in the rat choroid plexus after chronic treatment with clozapine.

1 reference

12 December 2020

Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptors.

1 reference

12 December 2020

Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs.

1 reference

12 December 2020

Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness

1 reference

12 December 2020

[3H]paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments.

1 reference

12 December 2020

Pharmacological profile of binedaline, a new antidepressant drug

1 reference

12 December 2020

Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites

1 reference

12 December 2020

Differential radioligand binding properties of [3H]5-hydroxytryptamine and [3H]mesulergine in a clonal 5-hydroxytryptamine1C cell line

1 reference

12 December 2020

Simultaneous determination of fluoxetine and norfluoxetine enantiomers in biological samples by gas chromatography with electron-capture detection

1 reference

12 December 2020

Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors.

1 reference

12 December 2020

Serotonin1c receptor reserve in choroid plexus masks receptor subsensitivity

1 reference

12 December 2020

Ethanol administration does not alter dopamine D1 and D2 receptor characteristics in rat brain.

1 reference

12 December 2020

Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake

1 reference

12 December 2020

Chronic citalopram and fluoxetine treatments upregulate 5-HT2c receptors in the rat choroid plexus

1 reference

12 December 2020

Putative selective 5-HT-2 antagonists block serotonin 5-HT-1c receptors in the choroid plexus.

1 reference

12 December 2020

Chronic mianserin treatment decreases 5-HT2 receptor binding without altering 5-HT2 receptor mRNA levels.

1 reference

12 December 2020